{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Durham",
      "state": "NC",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "78170",
      "recalling_firm": "United Therapeutics Corp.",
      "address_1": "55 Tw Alexander Dr",
      "address_2": "N/A",
      "postal_code": "27709-0152",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "PA",
      "recall_number": "D-0083-2018",
      "product_description": "TYVASO (treprostinil) Inhalation Solution Treprostinil 1.74 mg/2.9 mL (0.6 mg/mL) Tyvaso Inhalation System Starter Kit Model# TD-100/A, Rx Only,  Manufactured by United Therapeutics Corporation Research Triangle Park, NC 27709, NDC# 6630220601",
      "product_quantity": "12 devices",
      "reason_for_recall": "CGMP Deviations",
      "recall_initiation_date": "20170911",
      "center_classification_date": "20171119",
      "termination_date": "20190403",
      "report_date": "20171129",
      "code_info": "Lot #: 2101152; Exp. 12/11/2017  Lot #: 2101195; Exp. 04/26/2019"
    }
  ]
}